KIORA PHARMACEUTICALS INC (KPRX) — Institutional Holders, Q2 2026
22 institutional investment managers reported a KPRX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.9M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
KPRX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- PERCEPTIVE ADVISORSNew · +438,471 sh+$1.2M
- TWO SIGMA INVESTMENTSNew · +88,792 sh+$233.5K
- MILLENNIUM MANAGEMENTNew · +74,202 sh+$195.2K
- CITADEL ADVISORSAdded · +66,478 sh+$174.8K
- HRT FINANCIALNew · +58,612 sh+$154.1K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -21,133 sh-$55.6K
- XTX Topco LtdSold out · -14,719 sh-$38.7K
- TWO SIGMA SECURITIESSold out · -12,019 sh-$31.6K
- Rangeley CapitalSold out · -10,000 sh-$26.3K
- Vanguard Global AdvisersSold out · -200 sh-$526.00
KPRX 13F holders ranked 1–22 of 22
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | PERCEPTIVE ADVISORS#1 · 438,471 sh | 438,471 | $1.2M | 0.02% | New |
| 2 | ADAR1 Capital Management#2 · 167,941 sh | 167,941 | $441.7K | 0.02% | 0.0% |
| 3 | CITADEL ADVISORS#3 · 116,011 sh | 116,011 | $305.1K | 0.00% | +134.2% |
| 4 | TWO SIGMA INVESTMENTS#4 · 88,792 sh | 88,792 | $233.5K | <0.01% | New |
| 5 | MILLENNIUM MANAGEMENT#5 · 74,202 sh | 74,202 | $195.2K | <0.01% | New |
| 6 | HRT FINANCIAL#6 · 58,612 sh | 58,612 | $154.0K | <0.01% | New |
| 7 | RENAISSANCE TECHNOLOGIES#7 · 29,824 sh | 29,824 | $78.4K | <0.01% | New |
| 8 | GEODE CAPITAL MANAGEMENT#8 · 26,717 sh | 26,717 | $70.3K | 0.00% | -44.2% |
| 9 | VANGUARD CAPITAL MANAGEMENT#9 · 19,861 sh | 19,861 | $52.2K | 0.00% | 0.0% |
| 10 | Scientech Research#10 · 18,746 sh | 18,746 | $49.3K | 0.04% | New |
| 11 | VANGUARD FIDUCIARY#11 · 13,030 sh | 13,030 | $34.3K | 0.00% | 0.0% |
| 12 | LPL Financial#12 · 12,500 sh | 12,500 | $32.9K | 0.00% | New |
| 13 | DIMENSIONAL FUND ADVISORS#13 · 12,138 sh | 12,138 | $31.9K | 0.00% | New |
| 14 | NORTHERN#14 · 11,767 sh | 11,767 | $30.9K | 0.00% | New |
| 15 | JANE STREET GROUP#15 · 10,615 sh | 10,615 | $27.9K | 0.00% | New |
| 16 | UBS Group AG#16 · 1,961 sh | 1,961 | $5.2K | 0.00% | +50.7% |
| 17 | Caitong International Asset Management , Ltd#17 · 1,813 sh | 1,813 | $4.8K | <0.01% | New |
| 18 | MORGAN STANLEY#18 · 1,408 sh | 1,408 | $3.7K | 0.00% | 0.0% |
| 19 | Tower Research Capital (TRC)#19 · 837 sh | 837 | $2.2K | <0.01% | -15.9% |
| 20 | SBI Securities , Ltd.#20 · 256 sh | 256 | $673.00 | — | 0.0% |
| 21 | BlackRock#21 · 58 sh | 58 | $153.00 | 0.00% | 0.0% |
| 22 | Activest Wealth Management#22 · 2 sh | 2 | $5.00 | — | 0.0% |
Funds that sold out of KPRX in Q2 2026 (5)
Held KPRX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| XTX Topco Ltd14,719 sh | 14,719 | $28.4K |
| TWO SIGMA SECURITIES12,019 sh | 12,019 | $23.2K |
| Rangeley Capital10,000 sh | 10,000 | $19.3K |
| Vanguard Global Advisers200 sh | 200 | $386.00 |
| OSAIC2 sh | 2 | $3.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.